Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co LtdfiledCriticalSSP Co Ltd
Priority to JP16628384ApriorityCriticalpatent/JPS6144867A/ja
Publication of JPS6144867ApublicationCriticalpatent/JPS6144867A/ja
Publication of JPH034548B2publicationCriticalpatent/JPH034548B2/ja
Способ получени N-десметилвинбластина, винкристина,N-десметиллейрозина,N-десметил-N-формиллейрозина, N-десметил-N-/этоксиметил/-винбластина,N-десметил-N-/этоксиметил/-лейрозина или их солей
Ellipticine derivatives with an affinity to the estrogen receptor. An approach to develop intercalating drugs with a specific effect on the hormone-dependent breast cancer